Concepedia

Publication | Open Access

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B

DOIFull Paper Access

121

Citations

6

References

2008

Year

Maureen M. Jonas, Déirdre Kelly, Henry Pollack, J. Mizerski, J. Sorbel, David Frederick, Elsa Mondou, Franck Rousseau, Étienne Sokal
Hepatology

Abstract

ADV showed significant antiviral efficacy in subjects aged 12 to 17 years with HBeAg+ CHB, but was not different from placebo in subjects aged 2 to 11 years.

References

YearCitations

Page 1